Compare Bath & Body Works Inc (BBWI) vs Five9 Inc (FIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Five9 Inc — how do they compare? Bath & Body Works Inc trades at $18.23 (market cap $3.81B), while Five9 Inc trades at $31.2 (market cap $2.44B). The key difference: Bath & Body Works Inc is the larger of the two by market cap, and Bath & Body Works Inc pays a 4.24% dividend while Five9 Inc pays none. Which is the better fit depends on your goals.
| BBWI | FIVN | |
|---|---|---|
Market Cap | $3.81B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $31.87 | $34.48 |
52-Week Low | $14.85 | $13.61 |
Enterprise Value | $7.70B | $2.59B |
Dividend Yield | 4.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BBWI trades at $18.28, down 5.38% over 24 hours, with a bearish technical signal from moving averages. The stock shows attractive valuation metrics with a P/E of 5.36 and P/S of 0.54, while maintaining strong gross margins above 43%. Recent earnings have mostly beaten expectations, and the company is expanding internationally through partnerships with Ulta Beauty and entry into Brazil. Cash flow trends show improvement, with positive net cash flow projected for 2026.
The investment case hinges on BBWI's deep value proposition against declining revenue trends. Key opportunities include international growth and strategic partnerships, while risks involve high debt levels and ongoing revenue pressure. Analyst consensus is mixed with a $22.11 price target suggesting upside potential from current levels.
Five9 (FIVN) trades at $31.14, down 9.69% today but remains near its 52-week highs. The stock shows strong technical momentum with bullish moving averages and has consistently beaten earnings estimates in recent quarters. Revenue growth accelerated to 10% in Q2 2026, reaching $312.4 million, while the company maintains a solid gross margin of 54.91%. Recent management appointments and AI-driven subscription growth provide positive catalysts.
The outlook remains positive with 61% analyst buy ratings and a $32.67 consensus target offering 5% upside. However, elevated valuation multiples (P/E 47.99) and ongoing fiduciary investigations pose risks. The stock's trajectory depends on continued execution of AI revenue growth and margin expansion targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →
